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Abstract Here we show that epidermal neural crest stem
cell (EPI-NCSC) transplants in the contused spinal cord
caused a 24% improvement in sensory connectivity and a
substantial recovery of touch perception. Furthermore we
present a novel method for the ex vivo expansion of EPI-
NCSC into millions of stem cells that takes advantage of
the migratory ability of neural crest stem cells and is based
on a new culture medium and the use of microcarriers.
Functional improvement was shown by two independent
methods, spinal somatosensory evoked potentials (SpSEP)
and the Semmes-Weinstein touch test. Subsets of trans-
planted cells differentiated into myelinating oligodendro-
cytes. Unilateral injections of EPI-NCSC into the lesion of
midline contused mouse spinal cords elicited bilateral
improvements. Intraspinal EPI-NCSC did not migrate
laterally in the spinal cord or invade the spinal roots and
dorsal root ganglia, thus implicating diffusible factors. EPI-
NCSC expressed neurotrophic factors, angiogenic factors,
and metalloproteases. The strength of EPI-NCSC thus is
that they can exert a combination of pertinent functions in
the contused spinal cord, including cell replacement,
neuroprotection, angiogenesis and modulation of scar
formation. EPI-NCSC are uniquely qualified for cell-
based therapy in spinal cord injury, as neural crest cells
and neural tube stem cells share a higher order stem cell
and are thus ontologically closely related.
Keywords Stem cell.Neural crest.Epidermal neural crest
stem cell.EPI-NCSC.Spinal cord.Spinal cord injury.
Somatosensory evoked potential.Semmes-Weinstein touch
test
Introduction
The aim of this study was to determine whether EPI-NCSC
grafts elicit improvement in the connectivity of sensory
pathways in the contused spinal cord. EPI-NCSC are
multipotent remnants of embryonic neural crest stem cells
in a postnatal location, the bulge of hair follicles [1, 2].
Ontologically, neural crest cells are closely related to neural
tube cells, as both are descendents of the same higher order
stem cell [3]. Previously we showed that intraspinal EPI-
NCSC survive in large numbers, integrate into the spinal
tissue, and that different subsets of cells express markers for
neurons, including GABAergic neurons, and for oligoden-
drocytes but not astrocytes or Schwann cells, and that the
scar is vascularized [4]. Importantly, as adult stem cells
intraspinal EPI-NCSC did not form tumors or teratomas in
the spinal cord [4]. The current study was aimed at
determining whether these advantageous characteristics of
intraspinal EPI-NCSC lead to functional improvement and
at elucidating some of the underlying mechanisms.
In treating spinal cord injury, four issues need to be
addressed in concert, that is (1) cell replacement, (2)
neurotrophic support, (3) neutralizing inhibitory factors
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inflammatory response [5]. Thus, combination therapies are
likely to constitute future treatments (see e.g., [6]).
Olfactory ensheathing cells (e.g., [7, 8]) umbilical blood
stem cells (e.g. [9]) and mesenchymal stem cells (e.g., [10])
are adult stem cells that have shown promise in treating
spinal cord injury. Progress in functional improvement by
modulating the glial scar has been made by systemic
application of anti-Nogo-A antibodies (see e.g. [6]) or with
chondroitinase treatment [11], while intraspinal delivery of
neurotrophic factors have been found to lead to neuronal
sparing and targeting (e.g., [12, 13]). The strength of EPI-
NCSC is that they fulfill at least three of the above
requirements simultaneously, that is cell replacement,
neurotrophic support and the ability to degrade extracellular
matrix molecules, which form a barrier for the regeneration
of projection neurons.
Material and Methods
Animals
Wild type C57BL6/J and C57BL/6-TgN(ACTbEGFP)1Osb
[14] mice, which express enhanced green fluorescent
protein (EGFP) ubiquitously, were purchased from The
Jackson Laboratory (Bar Harbor, ME). Mice were main-
tained, bred, euthanized and surgery was performed at the
Transgenic Mouse Facility of the Medical College of
Wisconsin according to the guidelines of the US Public
Health Service’s Policy of Humane Care and Use of
Animals, the Guide for the Care and Use of Laboratory
Animals and with the approval of the Institutional Animal
Care and Use Committee of the Medical College of
Wisconsin.
Bulge Explants
Bulge explants from whisker follicles of 10–12 week-old
C57BL/6-TgN(ACTbEGFP)1Osb mice were prepared ex-
actly as described previously [1, 2, 15, 16]. Briefly, whisker
follicles were dissected, cleaned, cut first longitudinally and
subsequently transversely below and above the bulge
region. The bulges were then rolled out of the capsule and
placed into collagen-coated culture plates where they
adhered to the substratum within one hour. Three to 4 days
post-explantation, cells started to emigrate from the bulge
explants onto the culture substratum. The culture medium
consisted of 85% Alpha-modified MEM, 10% fetal calf
serum and 5% day-11 chick embryo extract. Three to four
days post-onset of emigration, bulges were removed and
the adhering cells detached by trypsin treatment and
subsequently subcultured.
Spinal Cord Injury and Cell Grafts
Mice were anesthetized by intraperitoneal injection of
1 mg/kg Domitor (Pfizer Animal Health, New York, NY
10017) and 75 mg/kg Ketamine (BEDFORD Laboratories,
Bedford, OH 44146). Surgery and spinal cord injury were
performed under sterile conditions as described previously
[4] with the modification that spinal cord injury was
performed on the midline, rather than on the left side of
the spinal cord, in order to injure both sides equally. Briefly,
a laminectomy was performed at thoracic level 8 (T8) and
moderate spinal cord injury was performed at the midline
with a modified Newton meter [4] at 12 centi-Newtons (cN)
for 3 s. Subsequently, in vitro expanded EPI-NCSC were
aspirated into a drawn capillary tube, the tip placed onto the
dura mater with a micromanipulator and injected 1 mm
deep into the left side of the spinal cord over a 4–5 min
time span each. Two injections at 0.8 microliter each were
made at approximately the rostral and caudal margins of the
injury with the aim to bridge the lesion. Equal volumes of
saline were injected in control animals. With this procedure,
no swelling of the spinal cord was observed, and the dorsal
spinal artery was not affected. On average 1:4  105 
2:3  104 cells per mouse were grafted. Subsequently, the
wound was closed with suture and wound clips (Fine
Science Tools Inc., Foster City, CA). The mice were placed
on a warming pad until they were alert and upright.
Spinal Evoked Potential (SpSEP) Measurements
SpSEPs were recorded from 19 spinal cord injured (SCI)
mice treated with EPI-NSC, 22 SCI mice treated with saline
and 6 uninjured mice 4 months following injury and
treatment.
The technique used to evoke SpSEPs has been described
previously [17]. Briefly, animals were anesthetized (as
above), shaved and securely taped to a Styrofoam surgical
board. For recording, two Teflon insulated 7-strand,
0.0254 mm diameter, stainless steel wires with a 3 mm
region of deinsulation (Fig. 1) were placed subcutaneously
at the level of T4, rostral to the site of injury. The recording
electrodes were connected to a high input impedance
module with an input impedance of 2 TΩ and capacitance
of 10 pF (Model HZP; Grass-Telefactor, West Warwick,
RI), which, in turn, was connected to an amplifier (Model
QP511 Quad AC Amplifier System; Grass-Telefactor, West
Warwick, RI). The amplifier was connected to a laptop
computer via a data acquisition board.
For stimulation, a 23 G needle (cathode) was placed
subcutaneously at the midline, 3 cm caudal to the most
caudal recording electrode. A blunt tipped, 23 G hypoder-
mic needle served as the anode. The anode was placed in a
position to stimulate the tibial nerve through the skin at the
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anode was adjusted to elicit plantar flexion of the hind paw
with a minimum stimulus current.
Somatosensorystimulitothetibialnerveweredeliveredby
a constant current nerve stimulator (Model DS7A; Digitim-
eter, Hertfordshire, UK). The stimulation frequency was
3.5 Hz and the pulse duration was 500 μs. Electrical
stimulation was delivered at three stimulus intensities: 1X,
2X and 3X the threshold current for motor response. Motor
threshold current was between 0.47 and 0.49 mA for all
animals and was similar across groups. Separate SpSEP
recordings were done for each leg and each stimulus intensity.
Continuous data were segregated into epochs; each
epoch was defined as the voltage recorded between −20
and 150 ms around the time of stimulus (0 ms). Each epoch
was baseline corrected and 700 epochs were ensemble
averaged for each recording to obtain the SpSEP waveform.
The amplitude of the mid- to long-latency component of the
SpSEP was defined as the range of signal amplitude
(maximum amplitude—minimum amplitude) between
8 and 25 ms after the stimulus [17, 18].
A two-way analysis of variance (ANOVA) with post-hoc
Tukey’s test was performed to compare the SpSEP ampli-
tudes across groups and limbs at each stimulus intensity. The
peak-to-peak amplitude of the mid latency SpSEP compo-
nent was taken as the dependent variable, with two fixed
factors: (i) the side of stimulation (left and right leg) and (ii)
the type of treatment (uninjured, EPI-NCSC injected and
saline injected mice). Threshold for statistical significance
was fixed at p<0.05 and SPSS 16.0 statistical software
(SPSS inc. Chicago, IL) was used for analysis.
Semmes-Weinstein Touch Test
Cutaneous sensation was evaluated using the Semmes-
Weinstein test according to manufacturer’s instructions. The
Touch-Test™ Sensory Evaluators (North Coast Medical
Inc, Morgan Hill, CA) consist of an array of filaments of
different thicknesses corresponding to specific weights
ranging from 0.008 to 300 g. The filament tip was aimed
at the middle of the paw and pressed at a 90°C angle
against the skin and held in place for 1.5–2 s. A clasping
reflex, when it occurred, was immediate, as was clonus.
Both ceased when the filament was removed. Clasping was
considered indicative of a response. Limbs were tested
multiple times and responses occurred reproducibly. In
order to avoid desensitization, there was a 2 min waiting
period between repeat tests. Threshold weight values for the
clasping reflex were used for statistical analysis. Data were
analyzed by ANOVA and post-hoc comparisons as de-
scribed for the SpSEP measurements.
Immuno-electron Microscopy
For immuno-electron microscopy spinal cords were fixed in
situ in order to preserve ultrastructure of the spinal cord tissue
asmuchaspossible.Miceweredeeplyanesthetized,thespinal
cordexposedandtransectedimmediatelyrostralandcaudalof
the lesion/graft. Severaldrops of4% paraformaldehyde (PFA)
were placed at the level of the cuts and on top of the spinal
cord. After 10 min, the mice were euthanized by anesthetic
overdose. The pertinent section of spinal cord was removed,
cut into smaller pieces and further incubated in 4% PFA in
0.1 M phosphate buffer at pH 7.3 for 30 min. The tissue
pieces were then inspected with the fluorescence micro-
scope for EGFP signal. Fluorescent pieces of tissue were
selected and further trimmed to approximately 200 µm
sized pieces in order to fit them into a cryo planchette from
a Leica EMPact II high pressure freezing apparatus. The
samples were high pressure frozen and freeze substituted in
ethanol containing 0.5% uranyl acetate into Lowicryl
K11M resin following the protocol of Ameye et al [19].
Ultrathin sections were cut and mounted on formvar-coated
copper grids and sections probed with anti-GFP polyclonal
rabbit serum (MBL Co Ltd, Naka-ku Nagoya, Japan). Anti-
GFP antibody was visualized using goat anti-rabbit 10 nm
gold probe (EMS, Hatfield, PA, USA) and viewed on a
Hitachi H600 transmission electron-microscope.
Fig. 1 Experimental setup for collecting spinal somatosensory
evoked potentials (SpSEPs). Teflon insulated stainless steel fine wire
electrode used for recording SpSEPs. The electrodes were positioned
subcutaneously above the vertebral body and paraspinal muscles. The
recording electrodes were connected to a high impedance module,
amplifier, and data acquisition system. Stimulating electrodes deliv-
ered electrical stimulation to the tibial nerve through the skin over the
popliteal fossa
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Mice were anesthetized by intraperitoneal injection of
Domitor (1 mg/kg, Pfizer Animal Health, New York, NY
10017) and Ketamine (75 mg/kg, BEDFORD Laboratories,
Bedford, OH 44146). A laminectomy was performed at
thoracic level 12. A sharpened tungsten needle the tip of
which had been coated with a concentrated solution of Alexa
Fluor 680-conjugated dextran (10,000 MW; Molecular
Probes/ Invitrogen, Carlsbad, California 92008 USA) and
subsequently dried [20] was placed on the left side of the
spinal cord, the dura punctured and the needle carefully
pushed 1 mm deep into the tissue. The wound was closed
with suture and wound clips (Fine Science Tools (USA), Inc.
Foster City, CA). The mice were placed on a warm pad until
they were awake and upright. After one week, animals were
anesthetized as described above and perfused intracardially
with 0.9% saline followed by a solution of 4% PFA in 0.1
molar phosphate buffer (pH 7.4). After perfusion, the spinal
cord was removed and postfixed in a fresh solution of the
same fixative at 4°C for over 24 h, and subsequently cryo-
protected and sectioned at 12 micrometer.
Real Time Polymerase Chain Reaction (qPCR)
For reverse transcription, total RNA was extracted with
TRIzol reagent (Invitrogen) and treated with DNaseI
(Invitrogen). First strand cDNA was synthesized using the
SuperScript III First Strand synthesis kit from Invitrogen,
with Oligo (dT) used as the primer according to manufac-
turer’s instructions. For quantitative PCR (qPCR), 10 µl
reactions consisted of 5 µl 2×RT
2 Real-Time SYBR Green/
ROX MasterMix (SABiosciences/Tebu-Bio), 0.5 µl First
Strand cDNA template and 0.5 µl RT
2 qPCR Primer Set
(SABiosciences/Tebu-Bio) and was brought to a 10 µl final
volume with ddH2O. Thermo-cycling conditions were as
follows: 95°C, 10 min and 40 cycles of 95°C, 15 s, 60°C
60 s and 80°C 30 s. Melting curve analysis showed a single
amplification peak for each reaction. Ct values for targets
were expressed as relative expression compared to the
average of three housekeeping genes (GAPDH, β-actin and
Ribosomal Protein S9).
Results
Ex Vivo Expansion of EPI-NCSC
All cells in primary explants were EGFP-positive (Fig. 2). For
sub-culturing, the bulge explants were removed, leaving the
EPI-NCSC in the culture plates. The cells were subsequently
detached by trypsin treatment and placed on a slurry of
hydrated sterile collagen microcarriers (50 mg dry weight; gift
of Titan Pharmaceuticals, South San Francisco, CA) in a
35 mm plastic Petri dish (Greiner Bio-One North America
Inc., Monroe, NC 28110) in 1.5 ml expansion medium. Cells
attached to the surface of the microcarriers within 30–60 min
and continued to divide rapidly (Fig. 3a, b). The culture
medium was exchanged every other day, and then daily
towards the end of the 9–10 day expansion period in
secondary culture. For medium changes, the entire culture
was transferred to a 15 ml centrifuge tube, the carriers allowed
to settle for 1–2 min, the supernatant medium removed,
replaced with an equal volume of fresh medium and the
culture then transferred back to a new 35 mm Petri dish.
The expansion medium consists of Neurobasal-A (without
Vitamin A; Invitrogen, Carlsbad, CA); 10% chick embryo
extract; 2% fetal bovine serum (Hyclone, Waltham, MA), B-
27 supplement (GIBCO/Invitrogen, Carlsbad, CA), ITS + 3
(insulin, transferrin selenium plus three essential fatty acids;
Sigma/Aldridge, St. Louis, MO), GlutaMAX (Invitrogen),
stem cell factor (10 ng/ml; R&D Systems, Minneapolis, MN),
neurotrophin 3 (20 ng/ml; Promega, Madison, WI), fibroblast
growth factor-2 (50 ng/ml; Upstate, Jaffrey, NH) and
epidermal growth factor (25 ng/ml; Sigma/Aldrich). During
ex vivo expansion key stemness genes (Myc, Klf2, Lin28,
Sox2andSox10)remainedexpressedatlevelssimilartothose
of embryonic stem cells (ESC) as determined by real-time
PCR (Fig. 3c). By contrast, Nanog and Oct-4 were 700–800
fold lower than in mouse embryonic stem cells (Fig. 3c).
Thus transcript levels were virtually identical to those we
have determined for unexpanded cells in primary explants
[21]. Typically we obtained 2 million expanded stem cells
from 15–20 bulge explants within 10–12 days.
Bilateral Improvement as Measured by Spinal
Somatosensory Evoked Potentials
A mid latency component of the SpSEP was observed in all
animals as a biphasic deflection occurring between 8 and
25 ms after the stimulus (Fig. 4a). This component reflects
the spinal cord conduction of myelinated A-fiber sensory
input to the lateral spinothalamic tract [22]. The short
latency SpSEP components (occurring around 5 ms post
stimulus) were obscured by the stimulus artifact in most
animals due to the extremely short conduction time
between the stimulating and recording electrodes in mice
[17]. Additionally, the long latency components, evoked by
C fiber input to the lateral spinothalamic tracts [23, 24]
were not observed in all animals, possibly because of the
low stimulus intensity used [17].
Analyses were performed at 4 months post-injury/stem
cell graft. Electrical stimulation of the left and right tibial
nerves were performed and SpSEP responses assessed. In
uninjured mice the average SpSEP response was 29.9±
5.1 microvolts and 29.08±7.3 microvolts upon stimulation
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respectively (Fig. 4b). By contrast, in negative control mice
that received a midline contusion and saline injection
instead of stem cells, the average SpSEP response dropped
to 6.05±2.1 and 6.39±2.0 microvolts on the left and right
sides, respectively (average of 20 mice; p<0.01). In mice
that received a midline contusion lesion and EPI-NCSC
grafts on the left side of the spinal cord, average SpSEP
response was 13.27±3.1 on the left side and 12.86±3.5 on
the right side, respectively (Fig. 4b). Notably, percent
changes were similar on the left and right hind legs. In
summary, the injury reduced SpSEPs to 20% of uninjured
mice, whereas in mice with a midline contusion and stem
cell implant on the left side of the spinal cord SpSEP
response was 44.4% of uninjured mice, which represents a
greater than 24% bilateral improvement.
Bilateral Improvement as Measured by Semmes–Weinstein
Touch Test
In parallel with SpSEP measurements, we performed the
Semmes–Weinstein touch test on mice from the same cohort
4 months after injury/graft. When there was no response even
at 300 g, the value of 300 g was used nevertheless. In saline
control mice, three offourlefthind legs and threeoffour right
hind legs did not show any response at 300 g. The results for
saline control mice thus represent an underestimate. On
average, the threshold response on the left hind leg was
7.7±0.9 g in non-injured mice, 242.2±29.9 in saline controls,
and 5.2±0.5 in mice with an EPI-NCSC graft (Table 1; p=
0.0001). Stimulation of the paw of the right hind leg resulted
in similar responses; 7.3±0.8 (non-injured), 141.5±50.2
(saline), and 5.2±0.5 (EPI-NCSC graft) grams (Table 1; p=
0.0001). Thus despite having grafted the stem cells in the left
side of the spinal cord only, recovery for touch perception
was bilateral, similar to the observations with SpSEP
measurements.
In some mice a clonus was observed in the hind limbs at
weights of 0.6–1.4 g, but not at higher probe weights. No
clonus presented in the forelimbs of experimental and
control groups. The lesion also affected the left and right
forelegs. The deficit was more pronounced in the left
forelimb (Table 1) and improved statistically significantly
over saline control in the presence of EPI-NCSC grafts
(Table 1; line 3, columns 1 and 2). These observations
indicate that the lesion at T8 caused deficiencies at more
rostral levels also, and that these were ameliorated on the
side of transplantation in the presence of EPI-NCSC grafts,
Fig. 2 Bulge explant from
whisker follicle. Bulge explants
were microdissected from whis-
ker follicles of C57BL/6-TgN
(ACTbEGFP)1Osb mice, in
which virtually all cells express
EGFP. a, green fluorescence; A’,
phase contrast optics; the explant
is surrounded by a halo of
emigrating cells with stellate
morphology. b, B’; boxed area in
A1 at higher magnification. All
EPI-NCSC are green
fluorescent
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saline controls. We tested for allodynia, both in the paws
and at the area of surgery. We did not observe retraction of
limbs in any of the mice or any obvious discomfort when
probed at the site of surgery. We thus conclude that at
4 months post-surgery allodynia was not present at
detectable levels. Overall, similar to the SpSEP data, the
Semmes–Weinstein touch test indicates a bilateral improve-
ment of sensory perception in the absence of allodynia.
Differentiation of Grafted EPI-NCSC into Myelinating
Oligodendrocytes
As we have shown previously, subsets of grafted EPI-
NCSC expressed oligodendrocyte markers, but not markers
for astrocytes or Schwann cells [4]. Here we show by
immuno-electron microscopy that grafted EPI-NCSC can
differentiate into myelinating oligodendrocytes (Fig. 5).
Grafted cells were able to myelinate processes elaborated
by other grafted cells (Fig. 5A’, c), as well as processes of
putative host cells (Fig. 5b,c). Thus at the subcellular level,
it became evident that subsets of intraspinal EPI-NCSC can
differentiate into functional oligodendrocytes.
Retrograde Transport
Tracing of processes by retrograde transport of Alexa-
conjugated dextran showed that red fluorescent retrogradely
transportingneurites andgraftedcells can intermingle (Fig. 6a-
A"), suggesting that at least some host neurites are able to
traverse the scar. Not only host neurites, but also a subset of
EPI-NCSC-derived green fluorescent neurites and cell bodies
showed red fluorescence (e.g., marked area in Fig. 6b-B”,
arrowhead). There were also green fluorescent grafted cells
that had not internalized the dye (Fig. 1b-B”, inset).
Absence of Grafted EPI-NCSC on the Right Side
of the Spinal Cord and Absence of Processes in the Dorsal
Root
Next we looked for explanations for the bilateral improve-
ment in sensory perception in the presence of unilateral
stem cell grafts. Intraspinal EPI-NCSC did not migrate
laterally to the right side of the spinal cord (Fig. 7). In
addition we inspected cross-sections at the level of graft
(Fig. 8a-A”’) and up to three segments below and above the
lesion. Figure 8b-B”’ show a section three levels above the
lesion. In none of the sections did we observe EGFP-
fluorescent cells or processes in the dorsal/ventral roots or
in the dorsal root ganglion. Together, the data show that
bilateral improvement was not due to cell migration and
therefore points to production of diffusible factors by
intraspinal EPI-NCSC.
Fig. 3 In vitro expansion of EPI-NCSC.( a, b) During in vitro
expansion, EPI-NCSC were cultured on collagen microcarriers. (A)
Enhanced green fluorescent protein fluorescence of cells growing on
microcarriers. Cells adhered to the surface of the microcarrier, divided
and migrated. At high cell densities, cells started to populate
neighboring microcarriers. (B), phase contrast optics of the same field
as in (A). The microcarriers are visible. (c) Validation of expression of
key stemness genes after expansion. Data were obtained by qPCR and
are expressed as fold-increase/decrease compared to expression levels
in mouse embryonic stem cells. The expression levels for all seven
genes are virtually the same as we have published for EPI-NCSC from
primary explants prior to expansion [21]. This result thus indicates
that stemness does not change significantly during ex vivo expansion
of mouse EPI-NCSC. Sox10, a neural crest stem cell marker, and Myc
are 8-fold and 10-fold higher expressed in EPI-NCSC than in mouse
ES cells, respectively. Klf4 and Sox2 are expressed at levels
comparable to those in embryonic stem cells, whereas Lin28 is
expressed at 80-fold lower levels than in ES cells. Like in non-
expanded EPI-NCSC Oct-4 and Nanog are expressed at several
hundred to thousand fold lower levels than in ES cells, which might
explain the observation that EPI-NCSC do not form tumors in the
mouse spinal cord
R
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and Matrix-Degrading Enzymes by EPI-NCSC
One explanation for the bilateral improvement of sensory
perception observed in our present study could be the
expression of growth factors by EPI-NCSC, which could
diffuse and thus affect the host environment bilaterally. We
here present evidence for the expression of three classes of
relevant factors, (1) neurotrophins and other growth factors,
(2) angiogenic factors and (3) metalloproteases and other
extracellular proteases capable of modifying scar formation.
EPI-NCSC express numerous neurotrophic factors,
including for instance nerve growth factor, brain-derived
neurotrophic factor, fibroblast growth factors, insulin-like
growth factor 1 and bone morphogenetic proteins (Table 2).
EPI-NCSC also express the angiogenic factors Vegfa and
Vegfb (Table 2).
Extracellular proteases are involved in the degradation of
extracellular matrix and release of membrane-bound growth
factors. In the spinal cord they have thus been applied to
modify scar formation (see e.g., [11]) and activation of
growth factors. EPI-NCSC express many metalloproteases
and other extracellular proteases, which break down
extracellular matrix. Mmp-2 breaks down denatured colla-
gen. Mmp-3 breaks down proteoglycans, fibronectin,
laminin, and collagens III, IV, IX, and X, whereas Mmp-
Table 1 Semmes-Weinstein touch test
Limb tested Threshold response ± SEM (gram)
EPI-NCSC graft Saline control Non-injured
Left hind leg 5.2±0.5
a 242.2±29.9
ab 7.7±0.9
b
Right hind leg 5.2±0.5
c 141.5±50.2
cd 7.3±0.8
d
Left front leg 1.2±0.3
e 2.7±0.8
e 1.8±0.5
Right front leg 1.1±0.2 2.3±0.7 1.4±0.2
a, b, c, dp=0.0001
ep=0.04
EPI-NCSC graft; n=4
Saline Control; n=5
Non-injure mice; n-6
Fig. 4 Somatosensory evoked
potentials.( a) Typical SpSEP
response from representative
mice from EPI-NCSC treated
group (study group, black trace)
and saline treated group (control
group, grey trace) and uninjured
group (stippled trace). The mid
latency component is much
larger in the EPI-NCSC treated
mouse. A short latency compo-
nent is also seen abutting the
stimulus artifact in the SpSEP
response obtained from the EPI-
NCSC treated mouse. However,
the short latency component was
obscured by the stimulus artifact
in most recordings. (b) Mean
amplitude of the mid-latency
SpSEP response across groups
and stimulation side (right or left
hind limb). Mid-latency SpSEP
amplitude from age matched
uninjured mice is also shown for
comparison
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matrix and pro-collagens (Table 2).
Discussion
In this study we showed that unilateral EPI-NCSC trans-
plants into midline spinal cord lesions caused bilateral
improvement in sensory connectivity and touch perception.
EPI-NCSC grafts elicited a 24% bilateral improvement in
sensory perception, as measured by SpSEP responses.
T o u c hp e r c e p t i o nw a ss i g n i f i c a n t l yi m p r o v e da l s o ,a s
determined by the Semmes Weinstein test, and there was
no allodynia. Furthermore, we have developed a protocol
for the ex vivo expansion of mouse EPI-NCSC into
millions of stem cells. We have also provided evidence
that subsets of grafted cells can acquire properties of
functional neurons, i.e. by SpSEP response and retrograde
transport, and that others differentiate into myelinating glia.
The latter are presumably oligodendrocytes, as we have
shown previously that intraspinal EPI-NCSC do not express
markers for astrocytes and Schwann cells, but express
epitopes specific to oligodendrocytes [4]. Finally, we
provide evidence that EPI-NCSC express multiple genes
that encode neurotrophic factors, angiogenic factors and
metalloproteases, the sum of which may explain the
observed bilateral functional improvements.
For the design of the expansion medium we relied on our
longSAGE gene expression profile, which revealed the
expression of relevant growth factor receptors [15]. The
Fig. 5 Differentiation of intraspinal EPI-NCSC into myelinating
oligodendrocytes. Immuno-electron microscopy showed that instras-
pinal EPI-NCSC can differentiate into myelinating oligodendrocytes.
a; low magnification of a cell showing the nucleus (n) and several
myelinated processes (p). A’; higher magnification of are boxed in A.
Several gold particles (e.g., arrows) are visible identifying the cells as
a transplanted EPI-NCSC-derived cell. Part of a myelinated (arrow-
head) process is visible. The process also contains gold particles (e.g.,
arrows), identifying it as a EPI-NCSC-derived process. b; another
EPI-NCSC-derived cell (arrows) has myelinated (arrowhead)a
process that does not contain gold particles (asterisk), and thus could
be of host origin. c; a third cell of EPI-NCSC origin (arrows) that
envelops processes of graft origin (arrow) and of presumably host
origin (e.g., asterisk) level
Stem Cell Rev and Rep (2010) 6:186–198 193addition of a small amount of fetal bovine serum had a
beneficial effect on cell attachment, which could be
replaced neither by fibronectin nor laminin. Expanded cells
still expressed essential stemness genes. In our view it is
preferable to expand stem cells at the lowest possible cell
density in order to avoid undesirable autocrine and para-
crine effects. For example, EPI-NCSC express TGF-βs, as
well as their cognate receptors [15]. Since TGF-β action
inhibits neural crest cell proliferation and induces their
differentiation [25, 26], high cell density would promote
cell differentiation, which is to be avoided during in vitro
expansion. The microcarrier culture system has several
advantages over culture on tissue culture plastic. There is a
drastic increase in substratum surface area, which accom-
modates millions of cells in a small culture plate and thus
reduces costs for growth factors. Since EPI-NCSC are
migratory and have a tendency to avoid each other, they
were able to populate adjacent microcarriers. Therefore
sub-culture was not necessary, but new microcarriers could
be added instead. An additional benefit of microcarrier
culture is that occasional dead cells detach and therefore are
removed with the supernatant during culture medium
exchanges. Finally, at the end of the culture period, the
stem cells can be isolated gently and efficiently by
dissolving the microcarriers with collagenase, which leads
to populations of virtually 100% viable and single cells.
An important aspect of the current study was improve-
ment of sensory connectivity and touch perception. We
show that intraspinal EPI-NCSC also did not migrate
laterally, nor did they invade the spinal roots or the dorsal
Fig. 6 Retrograde transport. EPI-NCSC were injected at T8. The
retrograde tracer was injected 4 segments below, at T12. a – A’’.
Image at level of graft. a, green fluorescence illumination showing
and area containing grafted cells. A’, same area as in a in far-red
fluorescence illumination. Many host fibers are visible. Several areas
are visible where host fibers traverse areas of grafted cells (e.g.,
circled areas). A’’; merged images of a and A’. b – B’’. Image at level
of graft that show EPI-NCSC-derived somata and fibers. b; Clusters of
EPI-NCSC (b, arrowhead) and cross sections of EPI-NCSC-derived
fibers are present (e.g., circled area). B’; same area as in b showing
far-red fluorescence of the retrograde tracer. B’’; Merged images b and
B’. Yellow areas indicate co-localization. A subset of cell bodies have
taken up and presumably transported the dye (e.g., arrowhead). Many
green-fluorescent processes are also red-fluorescent (e.g., circled
area). The inset shows a higher magnification of a mixture of cross-
sectioned fibers, some of which do not contain the retrograde tracer,
whereas others are both green and red fluorescent as indicated by
yellow color. From retrograde tracing experiments we can conclude
that (1) host fibers can traverse the graft; (2) some graft-derived cells
can internalize and retrogradely transport the tracer, indicating that
their processes can reach up to four segments below the site of
grafting and (3) that they show an aspect of functionality by being
able of retrograde transporting
194 Stem Cell Rev and Rep (2010) 6:186–198root ganglia. We thus conclude that a likely mechanism for
functional improvement on both sides of the spinal cord is
the production, release and diffusion of trophic factors,
angiogenic factors and/or enzymes that can modify scar
formation. This notion is supported by our real-time PCR
data presented in Table 2. It can be envisioned that EPI-
NCSC derived growth factors diffuse from the graft and
thus can have a bilateral protective and/or regenerative
effects on the host tissue. By contrast, or in addition, they
could also serve to activate endogenous regeneration
mechanisms, as has been suggested for instance by
Hooshmand et al. [27]. The injury spread rostrally. In the
presence of EPI-NCSC grafts, the rostral spread of the
injury was significantly diminished on the left side only,
Fig. 8 Absence of elements of grafted cells in spinal roots and
ganglia. Cross sections of spinal cords containing EPI-NCSC grafts
were inspected at the level of the graft and at several segments above
and below the graft to determine whether intraspinal EPI-NCSC . (a –
A’’’) show the level of the graft. a, phase contrast optics; A’, higher
magnification of boxed area in a; green fluorescent grafted cells are
present in the spinal cord, but not in the dorsal root. A’’,A ’’’; higher
magnification of area boxed in A labeled A’’,A ’’’ showing a section of
the dorsal and ventral roots in phase contrast optics (A’’) and green
fluorescence (A’’’). No EPI-NCSC derived cell or fibers are present.
(b–B’’’) Section of same spinal cord as in a with EPI-NCSC graft,
three segments above the site of grafting. b, phase contrast optics. B’,
green fluorescence image with DAPI stain of boxed area in b, which
shows the left dorsal root. No fluorescent cells or fibers are present.
B’’, green fluorescence of contra lateral dorsal root. No EPI-NCSC-
derived cells or fibers are present. B’’’; area of lesion three segments
below in green fluorescence illumination. No EPI-NCSC are present
at that level
Fig. 7 Location of graft. Cross sections of the spinal cord at the level
of the injury and graft showed that the EPI-NCSC graft remained on
the left side of the spinal cord. No EPI-NCSC were observed in other
locations. Importantly they were not observed on the right side of the
spinal cord. a, phase contrast optics; b, boxed area in a at higher
magnification and under fluorescence illumination. Green fluorescent
cells are grafted cells. They are localized at the site of injection. Since
grafts were not globular, a cluster of cells can be seen in this section
that seems to be disconnected from the main graft
Stem Cell Rev and Rep (2010) 6:186–198 195suggesting that the mechanism of action is cellular, such as
the observed remyelination. While the current effect is
small, it warrants further investigation in future studies.
Since the contusion was applied to the dorsal column, the
SpSEPs recorded in the current study may have originated
from action potentials in the lateral spinocerebellar or
spinothalamic tracts. Of these tracts, the spinocerebellar tract
is expected to have a larger contribution to the SpSEP since
the stimulus primarily activated large diameter sensory fibers,
and spinothalamic tracts are more generally associated with
pain and temperature sensation (i.e. high-threshold afferents).
In addition, mid-latency evoked potentials of the mouse have
previously been associated with spinocerebellar pathways
[28], which are located within the lateral tracts of the spinal
cord. These tracts, which carry proprioceptive information
from large diameter afferents, were more likely to be spared
by the contusion injury in the current study. Thus, the
retention of SpSEPs with EPI-NCSC transplants might have
reflected a relative sparing of the spinocerebellar tracts. This
would be consistent with a neuroprotective effect of the EPI-
NCSC. Despite this functional improvement, allodynia was
not observed 4 months post-injury/surgery.
An alternative explanation for the larger SpSEPs and lower
Semmes-Weinstein threshold is an increased excitability of the
lumbosacral spinal cord to afferent drive in EPI-NCSC
transplanted mice. An increased caudal spinal cord excitability
could produce a larger ascending action potential. After a
spinal cord injury, it is common for the excitability of spinal
reflexes to increase, as reflected by lower thresholds for H
reflexes in spinal contused rats [29] and decreases in rate
depression in spinal transected rats [30]. A generalized
hyperexcitability of spinal cord neurons in chronic injury
h a sa l s ob e e nd o c u m e n t e di nr a t su s i n gf M R I[ 31]. Further,
the clonus observed in the EPI-NCSC transplanted mice is
analogous to clonus in humans [32], which occurs in nearly
70% of patients with spinal cord injury [33]. While reflex
excitability was not directly measured in the current study,
observations of clonus are consistent with greater spinal
excitability in the EPI-NCSC transplanted mice. The obser-
vation of a larger SpSEP and lower sensory threshold might
be the result an increased excitability of the lumbosacral
spinal cord, which could result in an increased synaptic drive
to spinocerebellar tracts, thereby increasing SpSEP amplitude.
EPI-NCSC express several metalloproteinases and other
extracellular proteases. There is an intriguing parallel between
the MRL/MpJ mouse and neural crest cells, and thus EPI-
NCSC,whichmaybe pertinent tothe beneficial effectsofEPI-
NCSC grafts in this model of spinal cord injury. The MRL/
MpJ mouse has extraordinary regenerative capacity as has
been shown for instance in an ear hole model [34]. This
observation has been ascribed to the expression of high levels
of matrix metalloproteinases and has been considered
causative to tissue regeneration [34]. As invasive migratory
cells that need to translocate through the extracellular matrix
Table 2 Expression levels of growth factors, Angiogenic factors and proteases
Ratio gene/average three
housekeeping genes
(mean ± S.E.M.)
Growth factors
Nerve growth factor (Ngf) 86.3±4.0
Brain derived neurotrophic factor (Bdnf) 80.6±3.7
Fibroblast growth factor-2 (Fgf2) 79.2±3.6
Fibroblast growth factor-7 (Fgf7) 89.9±3.8
Transforming growth factor-2 (Tgfb2) 70.9±3.4
Insulin-like growth factor-2 (Igf2) 75.9±3.5
Bone morphogenetic protein-1 (Bmp1) 82.9±2.9
Bone morphogenetic protein-2 (Bmp2) 66.0±3.1
Angiogenic factors
Vascular endothelial growth factor A (Vegfa) 93.9±2.4
Vascular endothelial growth factor B (Vegfb) 83.5±3.3
Metalloproteases
Matrix metallopeptidase-2(Mmp2) 97.9±3.4
Matrix metallopeptidase-3 (Mmp3) 92.4±4.9
Matrix metallopeptidase-14 (Mmp14) 94.2±2.6
A disintegrin-like and metallopeptidase (reprolysin type)
with thrombospondin type 1 motif (Adamts1)
78.8±2.7
Individual expression levels of housekeeping geneswere as follows; Gapdh, 94.5±3.5; β-actin, 105.1±2.6; RPS9 (ribosomal protein S9),108.7±2.8
196 Stem Cell Rev and Rep (2010) 6:186–198in the embryo to reach their target locations, it is an inherent
property of neural crest cells to express matrix-degrading
enzymes. We have shown in this study with a few examples
that EPI-NCSC indeed express metalloproteases and other
extracellular proteases. Timp-2 inhibits Mmp-2. The ratio of
Mmp-2/Timp-2 in EPI-NCSC is 1.5 according to the
LongSAGE gene expression profile [15]. This value equals
or exceeds that in MRL/MpJ mice (1.09–1.6; [34]), indicating
a high level of metalloproteinase activity in the microenvi-
ronment of EPI-NCSC. Elevated levels of metalloproteases
alone, however, cannot be responsible for functional im-
provement, as has been shown in the MRL/MpJ mouse [35].
We nevertheless can conclude that metalloproteases released
by EPI-NCSC are likely to participate actively in the
remodeling of extracellular matrix during scar formation and
thus potentially reduce the barrier effect of the scar. Proteases
may also promote the release of relevant membrane-bound
growth factors in host cells and/or grafted cells.
In summary, EPI-NCSC, unlike other types of stem cell,
combine several desirable features that can be causative to
improved sensory connectivity and touch perception in this
mouse model of spinal cord injury. While there are some
differences between murine and human EPI-NCSC (Clewes
et al, unpublished), and mouse models are not ideal to
assess human conditions, our present study nevertheless
shows that EPI-NCSC are attractive candidates for the
treatment of spinal cord injury, as they combine a number
of aspects relevant to cell-based combination therapy.
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